Combined radiation therapy and chemotherapy for carcinoma of the cervix

Cancer Journal

Volumn 7, Issue 2, 2001, Pages 86-94

  Rose, P G ^a   Eifel, P J ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; HYDROXYUREA; MITOMYCIN C; PACLITAXEL; TIRAPAZAMINE;

CANCER SURVIVAL; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MICE; RANDOMIZED CONTROLLED TRIALS; UTERINE CERVICAL NEOPLASMS;

EID: 0035048086     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Global cancer statistics
2. The disproportionately lower cancer survival rate with increased incidence and mortality in minorities and underserved Americans
3. Clinical dose-response curves of human malignant epithelial tumours
4. Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation
5. Neutron therapy in cervical cancer: Results of a phase III RTOG study
6. A comparison of intracavitary versus interstitial irradiation on the treatment of cervical cancer
7. High dose rate intracavitary brachytherapy for carcinoma of the cervix: The Madison system: I. Clinical and radiobiological considerations
8. The effect of treatment duration in the local control of cervix cancer
9. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies
10. Analysis of sites and causes of failure of irradiation in invasive squamous cell carcinoma of the intact uterine cervix
11. Essai randomisé de chimiothérapie initiale dans 151 carcinomes du col utérin localement étendus (T2b-N1, T3b, MO)
12. Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous cell carcinoma
13. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: A pilot study and phase III randomized trial
14. Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix
15. Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: Cisplatin followed by radiation therapy - A pilot study of the Gynecologic Oncology Group
16. Combined chemotherapy and radiotherapy in patients with advanced squamous carcinoma of the cervix (cis-platinum - Bleomycin - Vinblastine)
17. A randomized trail of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix
18. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer
19. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma
20. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer
21. Neoadjuvant chemotherapy (CT) + radiotherapy vs radiotherapy alone in stage IIIB cervical carcinoma: Preliminary results
22. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study
23. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma: A randomized multicancer study of sequential cisplatin and 5-fluorouracil and radiotherapy in aced carvical carcinoma stage 3B and 4A
24. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)
25. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer
26. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer
27. The hazard of accelerated tumor clonogen repopulation during radiotherapy
28. Hydroxyurea with irradiation for cervical carcinoma: A preliminary report
29. Hydroxyurea and radiation therapy in advanced cervical cancer
30. Hydroxyurea as a radiation senitizer in women with carcinoma of the uterine cervix
31. Hydroxyurea: A radiation potentiator in carcinoma of the uterine cervix. A randomized double-blind study
32. Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically stage IIIB cervical cancer
33. Hydroxyurea or placebo combined with radiation to treat stages IIB and IV cervical cancer confined to the pelvis
34. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group trial
35. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays
36. Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: Preliminary results of a phase I-II study
37. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer
38. Phase II randomized trial of cisplatin chemotherapy regimes in the treatment of recurrent of metastatic squamous cell cancer of the cervix. A Southwest Oncology Group Study
39. A randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix. A Gynecologic Oncology Group study
40. Effect of cisplatin on the clinically relevant rediosensitivity of human cervical carcinoma cell lines
41. A review of interactions between platinum coordination complex and ionizing radiation: Implications for cancer therapy
42. Experimental studies on schedule dependence in the treatment of cancer with combinations of chemotherapy and radiotherapy
43. Curability of mouse L1210 leukemia by combination of gamma rays
44. Effect of cis-dichlorodiammine platinum II and X rays on mammalian cell survival
45. Effect of cisplatin resistance on cellular radiation response
46. 5-Fluorouracil, leucovorin, hydroxyurea and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: A clinical and pharmacologic study
47. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: A phase I-II trial of the Gynecologic Oncology Group
48. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study
49. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: A randomized Radiation Therapy Oncology Group clinical trial
50. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas
51. Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study
52. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: Results of a randomized Gynecologic Oncology Group Study
53. 1975 Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
54. Radical hysterectomy for stage 1B1 vs 1B2 carcinoma of the cervix: Does the new staging system predict morbidity and survival?
55. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hyterectomy in bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group
56. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of- care-study
57. The effect of treatment duration in the local control of cervix cancer
58. Chemoradiation and adjuvant chemotherapy in cervical cancer
59. Cis-diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer
60. Concurrent chemotherapy and radiation for locally advanced cervical cancer: The new standard of care
61. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variable in the Gynecologic Oncology Group
62. The morbidity and utility of a periaortic radiotherapy in cervical carcinoma
63. Five-year survival (NED) in patient with biopsy confirmed aortic node metastasis from cervical carcinoma
64. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10
65. Cervical carcinoma metastatic to the para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy therapy
66. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma
67. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: A pilot study
68. Paclitaxel: A radiation sensitizer of human cervical cancer cells
69. The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine
70. X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts
71. Tirapazamine: Hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay
72. Camptothecin radiation sensitization: Mechanisms, schedules, and timing
73. A clinical trial comparing concurrent cisplatin and radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group
74. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix